| pubmed-article:19088172 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19088172 | lifeskim:mentions | umls-concept:C0684249 | lld:lifeskim |
| pubmed-article:19088172 | lifeskim:mentions | umls-concept:C0034802 | lld:lifeskim |
| pubmed-article:19088172 | lifeskim:mentions | umls-concept:C0027627 | lld:lifeskim |
| pubmed-article:19088172 | lifeskim:mentions | umls-concept:C0026882 | lld:lifeskim |
| pubmed-article:19088172 | lifeskim:mentions | umls-concept:C0033681 | lld:lifeskim |
| pubmed-article:19088172 | lifeskim:mentions | umls-concept:C1707455 | lld:lifeskim |
| pubmed-article:19088172 | lifeskim:mentions | umls-concept:C0205225 | lld:lifeskim |
| pubmed-article:19088172 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:19088172 | pubmed:dateCreated | 2009-3-26 | lld:pubmed |
| pubmed-article:19088172 | pubmed:abstractText | Mutations of the epidermal growth factor receptor (EGFR) gene in non-small-cell lung cancer (NSCLC) patients predict the patients who will respond to EGFR tyrosine kinase inhibitor (TKI) treatment. A recent study has suggested that 33% of NSCLC showed primary tumor/metastasis discordance of EGFR expression by immunohistochemistry analysis. We intended to find out whether the EGFR mutations of primary lung cancers are concordant to that of corresponding metastatic tumors. | lld:pubmed |
| pubmed-article:19088172 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19088172 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19088172 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19088172 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19088172 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19088172 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19088172 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19088172 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:19088172 | pubmed:issn | 1569-8041 | lld:pubmed |
| pubmed-article:19088172 | pubmed:author | pubmed-author:DewBB | lld:pubmed |
| pubmed-article:19088172 | pubmed:author | pubmed-author:GuD NDN | lld:pubmed |
| pubmed-article:19088172 | pubmed:author | pubmed-author:JinS KSK | lld:pubmed |
| pubmed-article:19088172 | pubmed:author | pubmed-author:HwuY JYJ | lld:pubmed |
| pubmed-article:19088172 | pubmed:author | pubmed-author:LeeY-CYC | lld:pubmed |
| pubmed-article:19088172 | pubmed:author | pubmed-author:YangP-CPC | lld:pubmed |
| pubmed-article:19088172 | pubmed:author | pubmed-author:YangC-HCH | lld:pubmed |
| pubmed-article:19088172 | pubmed:author | pubmed-author:ChangY-LYL | lld:pubmed |
| pubmed-article:19088172 | pubmed:author | pubmed-author:TsaiM-FMF | lld:pubmed |
| pubmed-article:19088172 | pubmed:author | pubmed-author:ShihJ-YJY | lld:pubmed |
| pubmed-article:19088172 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19088172 | pubmed:volume | 20 | lld:pubmed |
| pubmed-article:19088172 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19088172 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19088172 | pubmed:pagination | 696-702 | lld:pubmed |
| pubmed-article:19088172 | pubmed:dateRevised | 2009-11-19 | lld:pubmed |
| pubmed-article:19088172 | pubmed:meshHeading | pubmed-meshheading:19088172... | lld:pubmed |
| pubmed-article:19088172 | pubmed:meshHeading | pubmed-meshheading:19088172... | lld:pubmed |
| pubmed-article:19088172 | pubmed:meshHeading | pubmed-meshheading:19088172... | lld:pubmed |
| pubmed-article:19088172 | pubmed:meshHeading | pubmed-meshheading:19088172... | lld:pubmed |
| pubmed-article:19088172 | pubmed:meshHeading | pubmed-meshheading:19088172... | lld:pubmed |
| pubmed-article:19088172 | pubmed:meshHeading | pubmed-meshheading:19088172... | lld:pubmed |
| pubmed-article:19088172 | pubmed:meshHeading | pubmed-meshheading:19088172... | lld:pubmed |
| pubmed-article:19088172 | pubmed:meshHeading | pubmed-meshheading:19088172... | lld:pubmed |
| pubmed-article:19088172 | pubmed:meshHeading | pubmed-meshheading:19088172... | lld:pubmed |
| pubmed-article:19088172 | pubmed:meshHeading | pubmed-meshheading:19088172... | lld:pubmed |
| pubmed-article:19088172 | pubmed:meshHeading | pubmed-meshheading:19088172... | lld:pubmed |
| pubmed-article:19088172 | pubmed:meshHeading | pubmed-meshheading:19088172... | lld:pubmed |
| pubmed-article:19088172 | pubmed:meshHeading | pubmed-meshheading:19088172... | lld:pubmed |
| pubmed-article:19088172 | pubmed:meshHeading | pubmed-meshheading:19088172... | lld:pubmed |
| pubmed-article:19088172 | pubmed:meshHeading | pubmed-meshheading:19088172... | lld:pubmed |
| pubmed-article:19088172 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19088172 | pubmed:articleTitle | Comparison of epidermal growth factor receptor mutations between primary and corresponding metastatic tumors in tyrosine kinase inhibitor-naive non-small-cell lung cancer. | lld:pubmed |
| pubmed-article:19088172 | pubmed:affiliation | Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan. | lld:pubmed |
| pubmed-article:19088172 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19088172 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:19088172 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| entrez-gene:1956 | entrezgene:pubmed | pubmed-article:19088172 | lld:entrezgene |
| http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:19088172 | lld:entrezgene |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19088172 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19088172 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19088172 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19088172 | lld:pubmed |
